Christopher G. Larsen, MD, FACS
Dr. Larsen is a board certified general otolaryngologist with special interests in sleep disordered breathing (pediatrics and adults), benign salivary gland conditions/salivary gland obstruction, and cranial nerve stimulation. He treats all disorders of the ears, nose and throat, with subspecialty capabilities in sialendoscopy and surgery for obstructive sleep apnea. He graduated with High Distinction from the University of Nebraska-Lincoln in 1997, and with High Distinction from the University of Nebraska Medical Center in 2001. He moved to Kansas City for KUMC general surgery and otolaryngology residency training from 2001-2006. Upon graduation, he joined the KU Otolaryngology faculty in July 2006. He is the division director for General Otolaryngology at KU and enjoys taking care of patients of all ages.
Education and Training
- BS, Biology, University of Nebraska, Lincoln, NE
- MD, Medical, Univ. of Nebraska-Medical Ctr., Omaha, Nebraska
- Residency, Otolaryngology - Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS
- Internship, General Surgery, University of Kansas School of Medicine, Kansas City, Kansas
Licensure, Accreditations & Certifications
- Board Certified, American Board of Otolaryngology - Head and Neck Surgery
- DEA Certificate Kansas, Drug Enforcement Administration
- DEA Certificate Missouri, Drug Enforcement Administration
- Kansas Medical License, Kansas State Board of Healing Arts
- Missouri Medical License, Missouri Board of Registration for the Healing Arts
- MO BNDD , Bureau of Narcotics and Dangerous Drugs Missouri Department of Health and Senior Services
Dr. Larsen is actively involved in clinical research, currently acting as the primary investigator for a new antifungal medication to treat otomycosis (fungal otitis externa). He is also one of the top enrolling physicians in the ADHERE clinical registry, tracking outcomes of upper airway stimulation surgery for one year after implantation. He started the regions first UAS program implanting Inspire in the Fall of 2016.